medigraphic.com
ISSN 1405-8871 (Print)

2019, Number 3

<< Back Next >>

Aten Fam 2019; 26 (3)

Metabolic Control in the Elderly with Vulnerable and Non-vulnerable Diabetes Mellitus Type 2

Galván OI, Álvarez AC, Gómez GA

Language: Spanish
References: 21
Page: 95-99
PDF size: 138.40 Kb.


ABSTRACT

Objective: To compare metabolic control in the elderly with and without vulnerability who are diagnosed with Diabetes Mellitus type 2 (DM2) in a firstlevel care unit in the State of Michoacán, México. Methods: cross-sectional and analytical study conducted in 151 adults over 65 years with DM2. Clinical history was performed, the Pfeiffer and Barthel questionnaire was applied to determine vulnerability, and clinical records were reviewed. Blood glucose and HbA1c results were recorded. Parameters of four recommendations for metabolic control were analyzed according to the Clinical Practice Guide (GPC). Results: 63 men and 88 women were assessed, 34.4% were identified as vulnerable (n=52); 65.5%, as non-vulnerable (n=99), the mean age was higher in vulnerable patients (p‹0.05). High blood pressure showed a higher proportion in the vulnerable group (P=0.0001). Metabolic control was identified in 60.60% of nonvulnerable patients (n=60) and 21.25% of vulnerable patients (n=11), with a risk 2.5 times greater than having no metabolic control in this group (p‹0.01). Conclusions: Vulnerable adults suffering from DM2 are at higher risk of not having metabolic control. The presence of other comorbidities such as hypertension, the level of cognitive impairment and the functional state, impact on this metabolic control.


REFERENCES

  1. Instituto Mexicano del Seguro Social. División de Excelencia Clínica. Coordinación de Unidades Médicas de Alta Especialidad. Diagnóstico y tratamiento de diabetes mellitus en el adulto mayor vulnerable. [Internet] México 2013: [citado 2019 Abr 22]. Disponible en: http://www.cenetec. salud.gob.mx/descargas/gpc/CatalogoMaestro/ imss_657_13_dxytxdedmenadultovulnerable/ imss_657_13_dxytxde_dm_en_adultovulnerableger.pdf

  2. Powell PW, Corathers SD, Raymond J, Streisand R. New Approaches to Providing Individualized Diabetes Care in the 21st Century. Current diabetes reviews. 2015;11(4):222-30.

  3. Secretaría de Salud. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. [Internet] México 2016: [citado 2019 Abr 15]. Disponible en: https://www. gob.mx/cms/uploads/attachment/file/209093/ ENSANUT.pdf

  4. Schwartz AV, Hillier TA, Sellmeyer DE. Older women with diabetes have a higher risk of falls. Diabetes Care 2002;25(10):1749-54.

  5. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5):265-80.

  6. Dardano A, Penno G, Del Prato S, Miccoli R. Optimal therapy of type 2 diabetes: a controversial challenge. Aging (Albany NY). 2014;6(3):187- 206.

  7. Ismail F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials. Ann Intern Med. 2011;154(8):554-59.

  8. De la Iglesia MJ, Dueñas HR, Onís VM, Aguado TC, Albert C, Luque R. Adaptación y validación al castellano del cuestionario de Pfeiffer (spmsq) para detectar la existencia de deterioro cognitivo en personas mayores de 65 años. Med Clin (Barc). 2001;117(4):129-34.

  9. Barrero C, García S, Ojeda A. Índice de Barthel (IB): Un instrumento esencial para la evaluación funcional y la rehabilitación. Revista Plasticidad y Restauración Neurológica 2005;4(1-2):81-5.

  10. Menéndez J, Guevara A, Arcia N, León Díaz EM, Marín C, Alfonso JC. Enfermedades crónicas y limitación funcional en adultos mayores: estudio comparativo en siete ciudades de América Latina y el Caribe. Rev Panam Salud Pública. 2005;17(5- 6):353-61.

  11. Berreta JA, Kociak D. Hipertensión arterial en adultos mayores. Tratamiento según comorbilidades y daño de órganos. Rev. Arg. De Gerontología y Geriatría 2017;31(2):52-9.

  12. Beck LH. The aging Kidney: defending a delicate balance of fluid and electrolytes. Geriatrics. 2000;55(4):26-8.

  13. Ahmed FA. Kidney disease in elderly: Importance of collaboration between geriatrics and nephrology. Aging Dis. 2018;9:745-47.

  14. Ahmed FA, Catic AG. Decision-making in geriatric patients with end-stage renal disease: thinking beyond Nephrology. J. Clin. Med. 2019;8(5):8-26.

  15. Miranda PE, Valles PM, Ortiz RE. Relation of the glycemic control, cognitive function and executive function in the elderly with type 2 Diabetes: Systematic Review. Enfermería Global. 2016;42:472-80.

  16. Cervantes RG, Villareal E, Galicia L, Vargas ER, Martínez L. Estado de salud en el adulto mayor en atención primaria a partir de una valoración geriátrica integral. Atención primaria 2014;47(6):329-35.

  17. Domínguez A, García JG. Valoración geriátrica integral. Aten Fam. 2014;21(1):20-3.

  18. Acosta Y, Gómez M, Venero M, Hernández OR, del Busto J. Comportamiento clínico epidemiológico de la diabetes mellitus en el anciano. Rev Ciencias Médicas. 2013;17(3):92-101.

  19. González J, Rodríguez R, Lavalle, F, González, A. Hemoglobina A1c: ¿una prueba precisa y confiable para el cuidado de la diabetes? Estudio prospectivo en México. Salud Pública de México. 2013;55(5):462-68.

  20. Ariza E, Camacho N, Londoño E, Niño C, Sequeda C, Solano C, et al. Factores asociados a control metabólico en pacientes diabéticos tipo 2. Salud Uninorte. 2005;(21):28-40.

  21. Durán JC, e investigadores del estudio Diagerca. Prevalencia de diabetes mellitus en pacientes geriátricos institucionalizados en la provincia de Cádiz. Estudio Diagerca. Rev Esp Geriatr Gerontol. 2012;47(3):114-18.




2020     |     www.medigraphic.com